RE: Biosynex turnover and comparisons with Nova8 May 2021 17:37
Biosynex made 75m€ in Q1 2021
2020 results : 153.9m€ (+338% comparés to 2019)
Net result 2020 : 31m€
Net margins 34%
Dividende : 0.2€ per share
10m shares only
******************
Yes, but by made you mean turn over. They are a good comparator though.
2020 - Biosyn Rev €154m, EBITDA €52m vs Nov Rev €312m, EBITDA €210m. So revenue was about double but EBITDA quadruple. However Q1 Biosyn €75m vs Nov €83m so you could argue biosynex is moving in the right direction.
Mcap Biosyn €266m vs Nov €339m.
A quick snapshot and you might think novacyt's share price isn't that egregious after all, but the difference in the amount of money actually being made is stark. We know novacyt has a war chest building up whilst Biosynex are still having to raise funds (as recently as January).